{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiduedipgtu4jr4ptlsr2j4oqnbtxtuj7pm5f2lzqbqxpy55oktpne",
    "uri": "at://did:plc:wwyqal4cnqhuwyacdj7rqq3n/app.bsky.feed.post/3mg3e6epgoi32"
  },
  "path": "/t/generalizability-vs-transportability-in-trials/28551?page=3#post_58",
  "publishedAt": "2026-03-02T12:39:28.000Z",
  "site": "https://discourse.datamethods.org",
  "textContent": "One other general problem is that NNT envisions a group of patients almost as if they are competing with each other to see who wins. I don’t like any measure that involves that. I’ve heard patients say, when told they have a 5 chances out of 100 of surviving 2 months, “I know I’m one of the 5”. We need to stick with absolute risk in [0, 1] as well as life expectancies IMHO.",
  "title": "Generalizability vs. Transportability in Trials"
}